Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
AtriCure, Inc.
AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices.
IPO Date: August 5, 2005
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $1.59B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.44 | 2.11%
Avg Daily Range (30 D): $0.84 | 2.66%
Avg Daily Range (90 D): $0.80 | 2.28%
Institutional Daily Volume
Avg Daily Volume: .17M
Avg Daily Volume (30 D): .57M
Avg Daily Volume (90 D): .49M
Trade Size
Avg Trade Size (Sh.): 74
Avg Trade Size (Sh.) (30 D): 49
Avg Trade Size (Sh.) (90 D): 48
Institutional Trades
Total Inst.Trades: 2,995
Avg Inst. Trade: $1.76M
Avg Inst. Trade (30 D): $2.5M
Avg Inst. Trade (90 D): $2.36M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.98M
Avg Closing Trade (30 D): $2.86M
Avg Closing Trade (90 D): $2.94M
Avg Closing Volume: 50.49K
       
News
Jul 23, 2024 @ 6:08 PM
AtriCure gains China's nod for heart surgery devic...
Source: Natashya Angelica
May 2, 2024 @ 12:01 PM
Cracking The Code: Understanding Analyst Reviews F...
Source: Benzinga Insights
May 2, 2024 @ 12:00 AM
Compared to Estimates, AtriCure (ATRC) Q1 Earnings...
Source: Zacks Equity Research
May 1, 2024 @ 9:30 PM
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Esti...
Source: Zacks Equity Research
Apr 19, 2024 @ 1:45 PM
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.14 $-.12
Diluted EPS $-.14 $-.12
Revenue $ $ 123.62M $ 7.55M
Gross Profit $ $ 92.63M $
Net Income / Loss $ $ -6.75M $ -23.4M
Operating Income / Loss $ $ -5.95M $ -25.99M
Cost of Revenue $ $ 30.99M $
Net Cash Flow $ $ -22.84M $ 2.72M
PE Ratio